GNGBY
Price
$20.00
Change
+$0.28 (+1.42%)
Updated
Jun 30 closing price
Capitalization
5.07B
QDEL
Price
$29.77
Change
+$0.95 (+3.30%)
Updated
Jul 1, 11:59 AM (EDT)
Capitalization
3.14B
30 days until earnings call
Interact to see
Advertisement

GNGBY vs QDEL

Header iconGNGBY vs QDEL Comparison
Open Charts GNGBY vs QDELBanner chart's image
Getinge AB
Price$20.00
Change+$0.28 (+1.42%)
Volume$2.78K
Capitalization5.07B
QuidelOrtho
Price$29.77
Change+$0.95 (+3.30%)
Volume$1.55K
Capitalization3.14B
GNGBY vs QDEL Comparison Chart in %
Loading...
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNGBY vs. QDEL commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNGBY is a Buy and QDEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (GNGBY: $20.00 vs. QDEL: $28.82)
Brand notoriety: GNGBY and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GNGBY: 32% vs. QDEL: 99%
Market capitalization -- GNGBY: $5.07B vs. QDEL: $3.14B
GNGBY [@Medical Specialties] is valued at $5.07B. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNGBY’s FA Score shows that 2 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • GNGBY’s FA Score: 2 green, 3 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, GNGBY is a better buy in the long-term than QDEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNGBY’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 3 bullish TA indicator(s).

  • GNGBY’s TA Score: 4 bullish, 3 bearish.
  • QDEL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GNGBY is a better buy in the short-term than QDEL.

Price Growth

GNGBY (@Medical Specialties) experienced а +5.65% price change this week, while QDEL (@Medical Specialties) price change was +4.23% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +7.34%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was +0.67%.

Reported Earning Dates

QDEL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+7.34% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNGBY($5.07B) has a higher market cap than QDEL($3.14B). GNGBY has higher P/E ratio than QDEL: GNGBY (24.88) vs QDEL (9.76). GNGBY YTD gains are higher at: 31.610 vs. QDEL (-35.309). GNGBY has higher annual earnings (EBITDA): 5.41B vs. QDEL (607M). GNGBY has more cash in the bank: 4.43B vs. QDEL (167M). QDEL has less debt than GNGBY: QDEL (2.61B) vs GNGBY (6.89B). GNGBY has higher revenues than QDEL: GNGBY (29.8B) vs QDEL (3B).
GNGBYQDELGNGBY / QDEL
Capitalization5.07B3.14B161%
EBITDA5.41B607M891%
Gain YTD31.610-35.309-90%
P/E Ratio24.889.76255%
Revenue29.8B3B994%
Total Cash4.43B167M2,655%
Total Debt6.89B2.61B264%
FUNDAMENTALS RATINGS
GNGBY vs QDEL: Fundamental Ratings
GNGBY
QDEL
OUTLOOK RATING
1..100
1216
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
8493
PRICE GROWTH RATING
1..100
4785
P/E GROWTH RATING
1..100
1415
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNGBY's Valuation (7) in the null industry is somewhat better than the same rating for QDEL (56) in the Medical Specialties industry. This means that GNGBY’s stock grew somewhat faster than QDEL’s over the last 12 months.

GNGBY's Profit vs Risk Rating (84) in the null industry is in the same range as QDEL (100) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to QDEL’s over the last 12 months.

GNGBY's SMR Rating (84) in the null industry is in the same range as QDEL (93) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to QDEL’s over the last 12 months.

GNGBY's Price Growth Rating (47) in the null industry is somewhat better than the same rating for QDEL (85) in the Medical Specialties industry. This means that GNGBY’s stock grew somewhat faster than QDEL’s over the last 12 months.

GNGBY's P/E Growth Rating (14) in the null industry is in the same range as QDEL (15) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to QDEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNGBYQDEL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 12 days ago
60%
Bearish Trend 19 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YLDE52.620.39
+0.75%
Franklin ClearBridge Enhanced Inc ETF
PABU66.860.31
+0.47%
iShares Paris-Algnd Clmt Optd MSCIUSAETF
BKIV36.36N/A
N/A
BNY Mellon Innovators ETF
DIPS7.45-0.01
-0.13%
YieldMax Short NVDA Option Inc Strgy ETF
EWJV34.75-0.11
-0.32%
iShares MSCI Japan Value ETF

GNGBY and

Correlation & Price change

A.I.dvisor tells us that GNGBY and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNGBY
1D Price
Change %
GNGBY100%
+1.42%
QDEL - GNGBY
31%
Poorly correlated
-0.17%
ESLOY - GNGBY
28%
Poorly correlated
+0.28%
SAUHY - GNGBY
25%
Poorly correlated
-0.69%
COO - GNGBY
25%
Poorly correlated
+0.03%
SSMXY - GNGBY
24%
Poorly correlated
+1.13%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with BIO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-0.17%
BIO - QDEL
52%
Loosely correlated
-1.09%
DHR - QDEL
51%
Loosely correlated
-0.63%
ITGDF - QDEL
50%
Loosely correlated
N/A
RVTY - QDEL
50%
Loosely correlated
-1.12%
XRAY - QDEL
50%
Loosely correlated
-0.31%
More